fesomersen   Click here for help

GtoPdb Ligand ID: 14081

Synonyms: BAY-2976217 | BAY2976217 | IONIS FXI-LRx | IONIS-FXI-LRx
Compound class: Nucleic acid
Comment: Fesomersen (IONIS-FXI-LRx) is a conjugated antisense oligonucleotide that selectively inhibits the expression of factor XI [1]. It is being explored as an anticoagulation therapy.
We provide the basic nucleotide sequence, without the modifications outlined in the INN record for this drug.
No information available.
Summary of Clinical Use Click here for help
Fesomersen was progressed to determine safety and efficacy as an anticoagulation therapy to reduce clotting in patients at high risk of thrombosis.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03582462 A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers Phase 1 Interventional Ionis Pharmaceuticals, Inc.
NCT04534114 Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug Phase 2 Interventional Bayer